Host: Mouse

Isotype: IgG1

Immunogen: a recombinant fusion protein consisting of amino acids 1-213 of human VHL

Form: Liquid

Formulation: In 10 mM PBS, 0.2% BSA, pH 7.4.

Preservative: ≤0.1% sodium azide

Positive Control: Prostate, kidney, lung, colon, breast, bladder, or thyroid carcinoma tissue

Comments: Recognizes the ~30 kDa von Hippel-Lindau (VHL) protein in prostate, lung, colon, breast, bladder or carcinoma tissue.

Ref.: Corliss, C.L., et al. 1997.Human Pathology 28, 459. Lee, S., et al. 1996. Proc. Natl. Acad. Sci. USA 93, 1770. Siemeister, G., et al. 1996. Cancer Res. 56, 2299. Tsuchiya, H., et al. 1996. Cancer Res. 56, 2881. Chen, F., et al. 1995. Cancer Res. 55, 4804. Duan, D.R., et al. 1995. Proc. Natl. Acad. Sci. USA 92, 6459. Duan, D.R., et al. 1995. Science 269, 1402. Iliopoulos, O., et al. 1995. Nat. Med. 1, 822. Kishida, T., et al. 1995. Cancer Res. 55, 4544. Kley, N., et al. 1995. Glia 15, 297. Wizigmann-Voos, S., et al. 1995. Cancer Res. 55, 1358.